Conference Coverage: SABCS 2025 Highlights
Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment
December 16, 2025
FACULTY CHAIR
Adam Brufsky, MD, PhD
University of Pittsburgh School of Medicine, PA, USA
Faculty Members
Nadia Harbeck, MD, PhD
Ludwig Maximilian University of Munich, Germany
Javier Cortés, MD, PhD
International Breast Cancer Center, Barcelona, Spain
Sara Tolaney, MD, MPH
Dana-Farber Cancer Institute, Boston, MA, USA
Reshma Mahtani, DO
Miami Cancer Institute, FL, USA
Joyce O’Shaughnessy, MD
Baylor Sammons Cancer Institute, Dallas, TX, USA
Mark Pegram, MD
Stanford University, CA, USA
REPORT TOPICS INCLUDE
- New and Emerging Treatments in HER2+ Metastatic BC (mBC)
- Evolving Options for HER2+ Early Breast Cancer
- New and Emerging Approaches in HR+, HER2– mBC (Oral SERDs)
- Cytotoxic Therapy for Triple-Negative Breast Cancer
- Immune Checkpoint Inhibition
